血液肿瘤患者感染的实验室诊断进展  

Laboratory diagnosis progress of hematologic malignancies co-infection

作　　者：马园园[1] 赛音其木格[2] 张梅[2] 王佳波[2] 李会波[2] 侯相麟[3] 

机构地区：[1]内蒙古医科大学研究生院,内蒙古呼和浩特010000 [2]鄂尔多斯市中心医院血液科,内蒙古鄂尔多斯017000 [3]兰州大学第一医院血液科,甘肃兰州730000

出　　处：《中华医院感染学杂志》2016年第7期1677-1680,共4页Chinese Journal of Nosocomiology

基　　金：甘肃省科技厅自然科学基金资助项目(3ZS041-A25-058)

摘　　要：感染是血液肿瘤治疗过程中最常见的并发症,其发病率和病死率极高,由于血液肿瘤患者本身的特殊性,其早期鉴别诊断的难度很大;该综述介绍了目前临床常用的感染诊断指标,包括C-反应蛋、白细胞介素-6、降钙素原水平并提出了近几年各实验室研究较多但还未用于临床的白细胞分化抗原-14和白细胞分化抗原-64,将有望成为诊断血液肿瘤合并感染诊断敏感而特异性的指标。Infection is the most common complication in the process of hematologic malignancies treatment.The morbidity and mortality caused by infections are very high.Due to the particularity of patients with hematologic malignancies,the early differential diagnosis is difficult.This review introduces the clinical commonly used diagnostic index of infections,including C-reactive protein,interleukin-6,procalcitonin,and puts forward an idea that leukocyte differentiation antigen-64 and leukocyte differentiation antigens-14,which have been studied in laboratory but not used at clinical practices,are expected to become sensitive and specific indicators for diagnosing hematologic malignancies.

关 键 词：血液肿瘤 感染 实验室 诊断 

分 类 号：R733[医药卫生—肿瘤]